Provided by Tiger Trade Technology Pte. Ltd.

Tenax Therapeutics

1.87
+0.01000.54%
Post-market: 1.870.00000.00%16:10 EDT
Volume:2.34M
Turnover:4.31M
Market Cap:69.98M
PE:-1.27
High:1.91
Open:1.86
Low:1.80
Close:1.86
52wk High:19.40
52wk Low:1.31
Shares:37.42M
Float Shares:17.52M
Volume Ratio:1.50
T/O Rate:13.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4685
EPS(LYR):-1.3412
ROE:-59.80%
ROA:-37.70%
PB:0.62
PE(LYR):-1.39

Loading ...

Aug 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Aug 13, 2024

Major Issues Report

Form 8-K - Current report
Aug 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2024

Major Issues Report

Form 8-K - Current report
Aug 06, 2024

Major Issues Report

Form 8-K - Current report
Jun 13, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2024

Major Issues Report

Form 8-K - Current report
Mar 28, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 28, 2024

Major Issues Report

Form 8-K - Current report
Feb 23, 2024

Major Issues Report

Form 8-K - Current report
Feb 20, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 20, 2024

Major Issues Report

Form 8-K - Current report
Feb 16, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 12, 2024

Major Issues Report

Form 8-K - Current report
Feb 08, 2024

Major Issues Report

Form 8-K - Current report
Feb 06, 2024

Major Issues Report

Form 8-K - Current report
Feb 06, 2024

Correspondence

Form CORRESP - Correspondence